BIOMAT Database Logo BIOMAT Database Logo

Primary cutaneous CD8+ and CD30+ T-cell lymphoproliferative disorders: case reports and clinical implications. 2019

Pamela Baldin, and Myat Marla Shwe, and Liliane Marot, and Pascal Van Van Eeckout, and Claire Dachelet, and Laurine Sacré, and Aline Berners, and Stephanie Olivier, and Alessandra Camboni
Department of Pathology, Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCL), Brussels.

BACKGROUND CD8+ CD30+ primary cutaneous T-cell lymphomas (PCTCL) are rare entities with overlapping pathological features and variable outcome. OBJECTIVE We sought to highlight the importance of correlation between pathological findings and clinical presentation for correct classification of the disease. METHODS Two cases of CD8+ CD30+ PCTCL were investigated. The first patient presented with a multiple necro-erythematous lesion of the limb and the second with a papulo-necrotic lesion of the eyelid. RESULTS Despite a different clinical presentation, pathological findings were similar in both cases. Clinico-pathological correlation led to a diagnosis of primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma in the first case and primary cutaneous anaplastic large-cell lymphoma in the second. The first patient died shortly after diagnosis and the second is alive without recurrence. CONCLUSIONS Clinico-pathological correlation is essential for the correct identification of these rare diseases.

UI MeSH Term Description Entries
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D016827 CD8 Antigens Differentiation antigens found on thymocytes and on cytotoxic and suppressor T-lymphocytes. T8 antigens are members of the immunoglobulin supergene family and are associative recognition elements in MHC (Major Histocompatibility Complex) Class I-restricted interactions. Antigens, CD8,Leu-2 Antigens,T8 Antigens, T-Cell,CD8 Antigen,Antigen, CD8,Antigens, Leu-2,Antigens, T-Cell T8,Leu 2 Antigens,T-Cell T8 Antigens,T8 Antigens, T Cell
D017730 Ki-1 Antigen A member of the tumor necrosis factor receptor superfamily that may play a role in the regulation of NF-KAPPA B and APOPTOSIS. It is found on activated T-LYMPHOCYTES; B-LYMPHOCYTES; NEUTROPHILS; EOSINOPHILS; MAST CELLS and NK CELLS. Overexpression of the Ki-1 antigen in hematopoietic malignancies make it clinically useful as a biological tumor marker. Signaling of the receptor occurs through its association with TNF RECEPTOR-ASSOCIATED FACTORS. Antigens, CD30,Antigens, Ki-1,Ber-H2 Antigens,CD30 Antigens,Ki-1 Antigens,Tumor Necrosis Factor Receptor Superfamily, Member 8,Ber-H2 Antigen,CD30 Antigen,TNFRSF8 Receptor,Antigen, Ber-H2,Antigen, CD30,Antigen, Ki-1,Antigens, Ber-H2,Antigens, Ki 1,Ber H2 Antigen,Ber H2 Antigens,Ki 1 Antigen,Ki 1 Antigens,Receptor, TNFRSF8

Related Publications

Pamela Baldin, and Myat Marla Shwe, and Liliane Marot, and Pascal Van Van Eeckout, and Claire Dachelet, and Laurine Sacré, and Aline Berners, and Stephanie Olivier, and Alessandra Camboni
Characterization of primary cutaneous CD8+/CD30+ lymphoproliferative disorders.
November 2015, The American Journal of dermatopathology,
Pamela Baldin, and Myat Marla Shwe, and Liliane Marot, and Pascal Van Van Eeckout, and Claire Dachelet, and Laurine Sacré, and Aline Berners, and Stephanie Olivier, and Alessandra Camboni
Current management of primary cutaneous CD30+ T-cell lymphoproliferative disorders.
November 2009, Oncology (Williston Park, N.Y.),
Pamela Baldin, and Myat Marla Shwe, and Liliane Marot, and Pascal Van Van Eeckout, and Claire Dachelet, and Laurine Sacré, and Aline Berners, and Stephanie Olivier, and Alessandra Camboni
[Primary cutaneous CD30+ lymphoproliferative disorders].
March 2010, Actas dermo-sifiliograficas,
Pamela Baldin, and Myat Marla Shwe, and Liliane Marot, and Pascal Van Van Eeckout, and Claire Dachelet, and Laurine Sacré, and Aline Berners, and Stephanie Olivier, and Alessandra Camboni
Primary cutaneous CD30(+) lymphoproliferative disorders.
August 2016, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
Pamela Baldin, and Myat Marla Shwe, and Liliane Marot, and Pascal Van Van Eeckout, and Claire Dachelet, and Laurine Sacré, and Aline Berners, and Stephanie Olivier, and Alessandra Camboni
Primary cutaneous CD30-positive lymphoproliferative disorders.
December 2003, Hematology/oncology clinics of North America,
Pamela Baldin, and Myat Marla Shwe, and Liliane Marot, and Pascal Van Van Eeckout, and Claire Dachelet, and Laurine Sacré, and Aline Berners, and Stephanie Olivier, and Alessandra Camboni
[Primary cutaneous CD30-positive T-cell lymphoproliferative disorders:report of a case].
June 2021, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Pamela Baldin, and Myat Marla Shwe, and Liliane Marot, and Pascal Van Van Eeckout, and Claire Dachelet, and Laurine Sacré, and Aline Berners, and Stephanie Olivier, and Alessandra Camboni
Presence of t(2;5) in primary CD30+ cutaneous lymphoproliferative disorders.
October 1996, Blood,
Pamela Baldin, and Myat Marla Shwe, and Liliane Marot, and Pascal Van Van Eeckout, and Claire Dachelet, and Laurine Sacré, and Aline Berners, and Stephanie Olivier, and Alessandra Camboni
CD30+ T-cell lymphoproliferative disorders.
February 2019, Chinese clinical oncology,
Pamela Baldin, and Myat Marla Shwe, and Liliane Marot, and Pascal Van Van Eeckout, and Claire Dachelet, and Laurine Sacré, and Aline Berners, and Stephanie Olivier, and Alessandra Camboni
Primary cutaneous CD30-positive T-cell lymphoproliferative disorders with biallelic rearrangements of DUSP22.
June 2013, The Journal of investigative dermatology,
Pamela Baldin, and Myat Marla Shwe, and Liliane Marot, and Pascal Van Van Eeckout, and Claire Dachelet, and Laurine Sacré, and Aline Berners, and Stephanie Olivier, and Alessandra Camboni
Expression of CD44 and CD44v6 in primary cutaneous CD30 positive T-cell lymphoproliferative disorders.
September 2002, Journal of cutaneous pathology,
Copied contents to your clipboard!